GYRE THERAPEUTICS INC
GYRE·403783103·US·Common Stock·Healthcare - Biotechnology-Activist
GYRE (GYRE THERAPEUTICS INC) is held by 39 institutional investors as of Q2 2026. Largest holders: BlackRock, Inc. ($6.6M), VANGUARD CAPITAL MANAGEMENT LLC ($5.8M), GEODE CAPITAL MANAGEMENT, LLC ($3.5M). Net institutional sentiment: Bullish.
39
Holders
(2 Elite)
$24.9M
Total Value
73% (41)
Consensus
30 buying - 11 selling
13F: Insider & Congress: Updated regularly
Who's Trading
Source dates: Price Oct 15, 2026 · Insiders Jun 22, 2026 · Activists May 7, 2026 · Congress none
InsiderYWYe WeiguoSell $19KJun 18, 2026
InsiderYWYe WeiguoExercise 3K shJun 18, 2026
InsiderYWYe WeiguoSell $17KJun 11, 2026
Checking access…
Top Holders
Checking access…
Showing 1-20 of 44
1 / 3
Continue exploring
Other Healthcare stocks held by institutions
417 holders · $300.5B
416 holders · $881.6B
401 holders · $151.5B
398 holders · $415.6B
395 holders · $98.9B
394 holders · $111.8B
391 holders · $230.3B
386 holders · $303.9B
386 holders · $52.4B
383 holders · $114.2B
Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer